APO Research
Talk to an analyst

APO RESEARCH · REPORT

Streptococcus Pneumoniae Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Analysis and Forecast 2026-2032

30 December 2025194 pages

Choose your research edition.

Industry ResearchStreptococcus Pneumoniae Polysaccharide Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Streptococcus Pneumoniae Polysaccharide Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Streptococcus Pneumoniae Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Streptococcus Pneumoniae Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Streptococcus Pneumoniae Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Streptococcus Pneumoniae Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine include Yuxi Watson Biotechnology Co., Ltd, Merck & Co.,Inc, Pfizer Inc, Chengdu Institute of Biological Products Co., Ltd, Beijing Minhai Biotechnology Co., Ltd, Beijing Kexing Biological Products Co., Ltd, Serum Institute of India Pvt. Ltd, Sanofi Pasteur and Glaxosmithkline Plc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Streptococcus Pneumoniae Polysaccharide Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Streptococcus Pneumoniae Polysaccharide Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Streptococcus Pneumoniae Polysaccharide Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Streptococcus Pneumoniae Polysaccharide Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Streptococcus Pneumoniae Polysaccharide Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Streptococcus Pneumoniae Polysaccharide Vaccine sales, projected growth trends, production technology, application and end-user industry.

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Company

Yuxi Watson Biotechnology Co., Ltd

Merck & Co.,Inc

Pfizer Inc

Chengdu Institute of Biological Products Co., Ltd

Beijing Minhai Biotechnology Co., Ltd

Beijing Kexing Biological Products Co., Ltd

Serum Institute of India Pvt. Ltd

Sanofi Pasteur

Glaxosmithkline Plc

China National Biotec Group

Astellas Pharma Inc

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Type

Single Dose Vial

Pre-Filled Syringe

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Application

Hospital

Clinic

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Streptococcus Pneumoniae Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Streptococcus Pneumoniae Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Streptococcus Pneumoniae Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Streptococcus Pneumoniae Polysaccharide Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Streptococcus Pneumoniae Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Streptococcus Pneumoniae Polysaccharide Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single Dose Vial Major Manufacturers Table 3. Pre-Filled Syringe Major Manufacturers Table 4. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends Table 8. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers Table 9. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges Table 10. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints Table 11. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2021-2026) & (K Units) Table 18. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2027-2032) & (K Units) Table 19. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Streptococcus Pneumoniae Polysaccharide Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Streptococcus Pneumoniae Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers, Product Type & Application Table 29. Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Streptococcus Pneumoniae Polysaccharide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 39. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 40. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 51. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 52. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 56. Yuxi Watson Biotechnology Co., Ltd Company Information Table 57. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 58. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 60. Yuxi Watson Biotechnology Co., Ltd Recent Development Table 61. Merck & Co.,Inc Company Information Table 62. Merck & Co.,Inc Business Overview Table 63. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 65. Merck & Co.,Inc Recent Development Table 66. Pfizer Inc Company Information Table 67. Pfizer Inc Business Overview Table 68. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 70. Pfizer Inc Recent Development Table 71. Chengdu Institute of Biological Products Co., Ltd Company Information Table 72. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 73. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 75. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 76. Beijing Minhai Biotechnology Co., Ltd Company Information Table 77. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 78. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 80. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 81. Beijing Kexing Biological Products Co., Ltd Company Information Table 82. Beijing Kexing Biological Products Co., Ltd Business Overview Table 83. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 85. Beijing Kexing Biological Products Co., Ltd Recent Development Table 86. Serum Institute of India Pvt. Ltd Company Information Table 87. Serum Institute of India Pvt. Ltd Business Overview Table 88. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 90. Serum Institute of India Pvt. Ltd Recent Development Table 91. Sanofi Pasteur Company Information Table 92. Sanofi Pasteur Business Overview Table 93. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 95. Sanofi Pasteur Recent Development Table 96. Glaxosmithkline Plc Company Information Table 97. Glaxosmithkline Plc Business Overview Table 98. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 100. Glaxosmithkline Plc Recent Development Table 101. China National Biotec Group Company Information Table 102. China National Biotec Group Business Overview Table 103. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 105. China National Biotec Group Recent Development Table 106. Astellas Pharma Inc Company Information Table 107. Astellas Pharma Inc Business Overview Table 108. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 110. Astellas Pharma Inc Recent Development Table 111. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 114. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 115. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 116. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 117. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 120. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 121. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 122. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 123. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 127. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 128. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 129. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 130. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 131. United States Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 132. Canada Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 133. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 134. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 135. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 136. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 137. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 138. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 139. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 142. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 143. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 144. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 150. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 151. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 152. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 153. Germany Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 154. France Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 155. U.K. Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 156. Italy Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 157. Netherlands Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 158. China Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 159. China Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 160. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 161. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 162. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 163. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 164. China Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 165. China Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 166. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 167. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 168. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 169. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 171. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 172. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 173. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 174. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 175. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 176. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 177. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 178. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 179. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 180. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 181. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 187. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 188. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 189. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Japan Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 191. South Korea Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 192. India Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Australia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 194. China Taiwan Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Southeast Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 196. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 197. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 198. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 199. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 200. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 201. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 202. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 203. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 204. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 205. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 206. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 207. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 208. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 212. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 213. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2027-2032) & (K Units) Table 214. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 215. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 216. Brazil Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Argentina Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Chile Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 219. Colombia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Peru Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Saudi Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Israel Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 223. UAE Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 224. Turkey Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 225. Iran Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 226. Egypt Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 227. Key Raw Materials Table 228. Raw Materials Key Suppliers Table 229. Streptococcus Pneumoniae Polysaccharide Vaccine Distributors List Table 230. Streptococcus Pneumoniae Polysaccharide Vaccine Customers List Table 231. Research Programs/Design for This Report Table 232. Authors List of This Report Table 233. Secondary Sources Table 234. Primary Sources List of Figures Figure 1. Streptococcus Pneumoniae Polysaccharide Vaccine Image Figure 2. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single Dose Vial Image Figure 5. Pre-Filled Syringe Image Figure 6. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (2021-2032) & (K Units) Figure 16. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Streptococcus Pneumoniae Polysaccharide Vaccine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Streptococcus Pneumoniae Polysaccharide Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 40. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 42. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 50. China Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 51. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 52. China Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 53. China Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 66. Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Streptococcus Pneumoniae Polysaccharide Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-Filled Syringe
Applications
  • Hospital
  • Clinic
Companies covered
  • Yuxi Watson Biotechnology Co., Ltd
  • Merck & Co.,Inc
  • Pfizer Inc
  • Chengdu Institute of Biological Products Co., Ltd
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Kexing Biological Products Co., Ltd
  • Serum Institute of India Pvt. Ltd
  • Sanofi Pasteur
  • Glaxosmithkline Plc
  • China National Biotec Group
  • Astellas Pharma Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Type
  3. 1.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single Dose Vial
  5. 1.2.3 Pre-Filled Syringe
  6. 1.3 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Application
  7. 1.3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Streptococcus Pneumoniae Polysaccharide Vaccine Market Dynamics
  1. 2.1 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends
  2. 2.2 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers
  3. 2.3 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region
  3. 3.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region
  9. 3.4.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Manufacturers
  6. 4.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Streptococcus Pneumoniae Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
5 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Type
  1. 5.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type
  2. 5.1.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type
  6. 5.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type
6 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Application
  1. 6.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application
  2. 6.1.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application
  6. 6.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application
7 Company Profiles
  1. 7.1 Yuxi Watson Biotechnology Co., Ltd
  2. 7.1.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  3. 7.1.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  4. 7.1.3 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  6. 7.1.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
  7. 7.2 Merck & Co.,Inc
  8. 7.2.1 Merck & Co.,Inc Company Information
  9. 7.2.2 Merck & Co.,Inc Business Overview
  10. 7.2.3 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  12. 7.2.5 Merck & Co.,Inc Recent Developments
  13. 7.3 Pfizer Inc
  14. 7.3.1 Pfizer Inc Company Information
  15. 7.3.2 Pfizer Inc Business Overview
  16. 7.3.3 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  18. 7.3.5 Pfizer Inc Recent Developments
  19. 7.4 Chengdu Institute of Biological Products Co., Ltd
  20. 7.4.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  21. 7.4.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  22. 7.4.3 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  24. 7.4.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  25. 7.5 Beijing Minhai Biotechnology Co., Ltd
  26. 7.5.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  27. 7.5.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  28. 7.5.3 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  30. 7.5.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  31. 7.6 Beijing Kexing Biological Products Co., Ltd
  32. 7.6.1 Beijing Kexing Biological Products Co., Ltd Company Information
  33. 7.6.2 Beijing Kexing Biological Products Co., Ltd Business Overview
  34. 7.6.3 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  36. 7.6.5 Beijing Kexing Biological Products Co., Ltd Recent Developments
  37. 7.7 Serum Institute of India Pvt. Ltd
  38. 7.7.1 Serum Institute of India Pvt. Ltd Company Information
  39. 7.7.2 Serum Institute of India Pvt. Ltd Business Overview
  40. 7.7.3 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  42. 7.7.5 Serum Institute of India Pvt. Ltd Recent Developments
  43. 7.8 Sanofi Pasteur
  44. 7.8.1 Sanofi Pasteur Company Information
  45. 7.8.2 Sanofi Pasteur Business Overview
  46. 7.8.3 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  48. 7.8.5 Sanofi Pasteur Recent Developments
  49. 7.9 Glaxosmithkline Plc
  50. 7.9.1 Glaxosmithkline Plc Company Information
  51. 7.9.2 Glaxosmithkline Plc Business Overview
  52. 7.9.3 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  54. 7.9.5 Glaxosmithkline Plc Recent Developments
  55. 7.10 China National Biotec Group
  56. 7.10.1 China National Biotec Group Company Information
  57. 7.10.2 China National Biotec Group Business Overview
  58. 7.10.3 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  60. 7.10.5 China National Biotec Group Recent Developments
  61. 7.11 Astellas Pharma Inc
  62. 7.11.1 Astellas Pharma Inc Company Information
  63. 7.11.2 Astellas Pharma Inc Business Overview
  64. 7.11.3 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  66. 7.11.5 Astellas Pharma Inc Recent Developments
8 North America
  1. 8.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Type
  2. 8.1.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2021-2032)
  5. 8.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Application
  6. 8.2.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2021-2032)
  9. 8.3 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country
  10. 8.3.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Streptococcus Pneumoniae Polysaccharide Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Type
  2. 9.1.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Application
  6. 9.2.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country
  10. 9.3.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Type
  2. 10.1.1 China Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2021-2032)
  5. 10.2 China Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Application
  6. 10.2.1 China Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Type
  2. 11.1.1 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Application
  6. 11.2.1 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country
  10. 11.3.1 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Streptococcus Pneumoniae Polysaccharide Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Type
  2. 12.1.1 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Application
  6. 12.2.1 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country
  10. 12.3.1 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Streptococcus Pneumoniae Polysaccharide Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Analysis
  2. 13.1.1 Streptococcus Pneumoniae Polysaccharide Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Streptococcus Pneumoniae Polysaccharide Vaccine Production Mode & Process
  6. 13.2 Streptococcus Pneumoniae Polysaccharide Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Streptococcus Pneumoniae Polysaccharide Vaccine Distributors
  9. 13.2.3 Streptococcus Pneumoniae Polysaccharide Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst